Abstract:The Huntington's disease mutation is a CAG repeat expansion in the huntingtin gene that results in an expanded polyglutamine tract in the huntingtin protein. The CAG repeat is unstable, and expansions of hundreds of CAGs have been detected in Huntington's disease post-mortem brains. The age of disease onset can be predicted partially from the length of the CAG repeat as measured in blood. Onset age is also determined by genetic modifiers, which in six cases involve variation in DNA mismatch repair pathways genes. Knocking-out specific mismatch repair genes in mouse models of Huntington's disease prevents somatic CAG repeat expansion. Taken together, these results have led to the hypothesis that somatic CAG repeat expansion in Huntington's disease brains is required for pathogenesis. Therefore, the pathogenic repeat threshold in brain is longer than (CAG) 40 , as measured in blood, and is currently unknown. The mismatch repair gene MSH3 has become a major focus for therapeutic development, as unlike other mismatch repair genes, nullizygosity for MSH3 does not cause malignancies associated with mismatch repair deficiency. Potential treatments targeting MSH3 currently under development include gene therapy, biologics and small molecules, which will be assessed for efficacy in mouse models of Huntington's disease. The zQ175 knock-in model carries a mutation of approximately (CAG) 185 and develops early molecular and pathological phenotypes that have been extensively characterised. Therefore, we crossed the mutant huntingtin allele onto heterozygous and homozygous Msh3 knock-out backgrounds to determine the maximum benefit of targeting Msh3 in this model. Ablation of Msh3 prevented somatic expansion throughout the brain and periphery, and reduction of Msh3 by 50% decreased the rate of expansion. This had no effect on the deposition of huntingtin aggregation in the nuclei of striatal neurons, nor on the dysregulated striatal transcriptional profile. This contrasts with ablating Msh3 in knock-in models with shorter CAG repeat expansions. Therefore, further expansion of a (CAG) 185 repeat in striatal neurons does not accelerate the onset of molecular and neuropathological phenotypes. It is striking that highly expanded CAG repeats of a similar size in humans cause disease onset before 2 years of age, indicating that somatic CAG repeat expansion in the brain is not required for pathogenesis. Given that the trajectory for somatic CAG expansion in the brains of Huntington's disease mutation carriers is unknown, our study underlines the importance of administering treatments targeting somatic instability as early as possible.

Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome

A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease

A modifier of Huntington's disease onset at the MLH1 locus

Small striatal huntingtin inclusions in patients with motor neuron disease with reduced penetrance and intermediate HTT gene expansions

Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice

A Hereditable Mutation of MSH2 Gene Associated with Lynch Syndrome in a Five Generation Chinese Family.

IT15 gene analysis in two pedigrees of Huntington's disease]

Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome

Htt Cag Repeat Expansion Confers Pleiotropic Gains Of Mutant Huntingtin Function In Chromatin Regulation

The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome

Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects

Mutant Huntingtin Protein Induces MLH1 Degradation, DNA Hyperexcision, and Cgas-Sting- Dependent Apoptosis

Ccg Polymorphisms in the Huntingtin Gene Have No Effect on the Pathogenesis of Patients with Huntington'S Disease in Mainland Chinese Families

Huntingtin Gene CAG Repeat Numbers in Chinese Patients with Huntington's Disease and Controls.

Functional Characterization of a Missense Variant of MLH1 Identified in Lynch Syndrome Pedigree.

The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

Huntingtin CAG repeat size variations outside the Huntington's disease complex: associations with depression and anxiety phenotypes and basal ganglia structure

Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum

Somatic CAG repeat instability in intermediate alleles of the HTT gene and its potential association with a clinical phenotype

Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome

A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease

A modifier of Huntington's disease onset at the MLH1 locus

Small striatal huntingtin inclusions in patients with motor neuron disease with reduced penetrance and intermediate HTT gene expansions

Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice

A Hereditable Mutation of MSH2 Gene Associated with Lynch Syndrome in a Five Generation Chinese Family.

IT15 gene analysis in two pedigrees of Huntington's disease]

Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome

Htt Cag Repeat Expansion Confers Pleiotropic Gains Of Mutant Huntingtin Function In Chromatin Regulation

The MSH2 c.793-1G&gt;A variant disrupts normal splicing and is associated with Lynch syndrome

Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects

Mutant Huntingtin Protein Induces MLH1 Degradation, DNA Hyperexcision, and Cgas-Sting- Dependent Apoptosis

Ccg Polymorphisms in the Huntingtin Gene Have No Effect on the Pathogenesis of Patients with Huntington'S Disease in Mainland Chinese Families

Huntingtin Gene CAG Repeat Numbers in Chinese Patients with Huntington's Disease and Controls.

Functional Characterization of a Missense Variant of MLH1 Identified in Lynch Syndrome Pedigree.

The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

Huntingtin CAG repeat size variations outside the Huntington's disease complex: associations with depression and anxiety phenotypes and basal ganglia structure

Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum

Somatic CAG repeat instability in intermediate alleles of the HTT gene and its potential association with a clinical phenotype

The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome